Lyndal K. Hesterberg
2016
In 2016, Lyndal K. Hesterberg earned a total compensation of $671.5K as Senior VP of Research and Development at Oncocyte Corp, a 1,205% increase compared to previous year.
Compensation breakdown
| Bonus | $12,625 |
|---|---|
| Option Awards | $414,873 |
| Salary | $35,125 |
| Other | $208,837 |
| Total | $671,460 |
Hesterberg received $414.9K in option awards, accounting for 62% of the total pay in 2016.
Hesterberg also received $12.6K in bonus, $35.1K in salary and $208.8K in other compensation.
Rankings
In 2016, Lyndal K. Hesterberg's compensation ranked 10,072nd out of 14,075 executives tracked by ExecPay. In other words, Hesterberg earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,072 out of 14,075 | 28th |
Division Manufacturing | 3,890 out of 5,486 | 29th |
Major group Chemicals And Allied Products | 1,371 out of 1,900 | 28th |
Industry group Drugs | 1,096 out of 1,543 | 29th |
Industry In Vitro and In Vivo Diagnostic Substances | 41 out of 65 | 37th |
Source: SEC filing on July 27, 2018.
Hesterberg's colleagues
We found two more compensation records of executives who worked with Lyndal K. Hesterberg at Oncocyte Corp in 2016.